Analysts Anticipate Acura Pharmaceuticals, Inc. (ACUR) Will Announce Earnings of -$0.12 Per Share

Analysts predict that Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) will announce ($0.12) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Zero analysts have made estimates for Acura Pharmaceuticals’ earnings. Acura Pharmaceuticals posted earnings of ($0.19) per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 36.8%. The firm is expected to report its next earnings results on Monday, November 13th.

On average, analysts expect that Acura Pharmaceuticals will report full-year earnings of ($0.46) per share for the current year. For the next fiscal year, analysts expect that the business will report earnings of $0.38 per share. Zacks’ earnings per share calculations are an average based on a survey of sell-side research firms that cover Acura Pharmaceuticals.

Acura Pharmaceuticals (NASDAQ:ACUR) last released its quarterly earnings results on Monday, August 14th. The specialty pharmaceutical company reported ($0.18) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.11) by ($0.07). Acura Pharmaceuticals had a negative net margin of 2,335.87% and a negative return on equity of 1,237.56%. The company had revenue of $0.09 million for the quarter.

TRADEMARK VIOLATION WARNING: This piece was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/2887129/analysts-anticipate-acura-pharmaceuticals-inc-acur-will-announce-earnings-of-0-12-per-share.html.

Acura Pharmaceuticals (NASDAQ:ACUR) traded down 4.62% during mid-day trading on Friday, reaching $0.45. The company’s stock had a trading volume of 22,250 shares. The stock’s market cap is $9.36 million. Acura Pharmaceuticals has a 12-month low of $0.40 and a 12-month high of $1.87. The firm’s 50 day moving average price is $0.46 and its 200 day moving average price is $0.52.

About Acura Pharmaceuticals

Acura Pharmaceuticals, Inc is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. The Company has discovered and developed three platform technologies, which can be used to develop multiple products.

Get a free copy of the Zacks research report on Acura Pharmaceuticals (ACUR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acura Pharmaceuticals (NASDAQ:ACUR)

Receive News & Ratings for Acura Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.